Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer
Study Information
Alliance Study ID: CALGB-SWOG-150506-80405-BRAF
NCT Study ID (ClinicalTrials.gov): NCT01243372
Alliance Committee: Gastrointestinal Cancer
Disease or Cancer Type: Colorectal / Colon / Rectal Cancer
Alliance Study Chair: Najjia N. Mahmoud, MD
Status: COMPLETED
Study Description
RATIONALE: Studying samples of tissue in the laboratory from patients who received cetuximab may help doctors understand and predict how well patients will respond to treatment.
PURPOSE: This research study is studying biomarkers in predicting response to cetuximab in patients with advanced colorectal cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information